Direct vat set probiotic leavening agent for relieving immune diseases and application of direct vat set probiotic leavening agent

A technology for immune diseases and probiotics, applied in the field of microbial fermentation, can solve problems such as insignificant effects, achieve important application value, relieve eczema, and improve physical conditions.

Pending Publication Date: 2022-05-13
JIANGSU WECARE BIOTECHNOLOGY CO LTD
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Some studies have found that probiotics can regulate and promote the body's immunity, and can relieve eczema to a certain extent, but the effect is not significant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] This embodiment provides a direct-throwing probiotic starter, which includes 22 parts of Streptococcus thermophilus ST81 fermentation product, 1 part of Lactobacillus bulgaricus LB42 fermentation product, and 5 parts of Lactobacillus rhamnosus LRa05 fermentation product in parts by weight , 13 parts of lactose, 8 parts of glucose, 7 parts of maltodextrin, 3.5 parts of butter powder, 0.05 parts of mannitol, 0.5 parts of sodium vitamin C, and 0.45 parts of Tween-80.

[0064] The preparation method is as follows: simple physical mixing of various raw materials, and vacuum freeze-drying to obtain the product.

Embodiment 2

[0066] This embodiment provides a direct-throwing probiotic starter, which includes 19 parts of Streptococcus thermophilus ST81 fermentation product, 3 parts of Lactobacillus bulgaricus LB42 fermentation product, and 5 parts of Lactobacillus rhamnosus LRa05 fermentation product in parts by weight , 15 parts of lactose, 3 parts of glucose, 5 parts of maltodextrin, 5 parts of butter powder, 3 parts of mannitol, 0.25 parts of sodium vitamin C, and 0.25 parts of Tween-80.

[0067] The preparation method is as follows: simple physical mixing of various raw materials, and vacuum freeze-drying to obtain the product.

Embodiment 3

[0069] This embodiment provides a direct-throwing probiotic starter, which includes 21 parts of Streptococcus thermophilus ST81 fermentation product, 2 parts of Lactobacillus bulgaricus LB42 fermentation product, and 5 parts of Lactobacillus rhamnosus LRa05 fermentation product in parts by weight , 18 parts of lactose, 5 parts of glucose, 2 parts of maltodextrin, 2 parts of butter powder, 1 part of mannitol, 0.1 part of sodium vitamin C, and 0.1 part of Tween-80.

[0070] The preparation method is as follows: simple physical mixing of various raw materials, and vacuum freeze-drying to obtain the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a direct-vat-set probiotic leavening agent for relieving immune diseases and application of the direct-vat-set probiotic leavening agent. The direct vat set probiotic leavening agent for relieving the immune diseases comprises a streptococcus thermophilus ST81 leavening, a lactobacillus bulgaricus LB42 leavening and a lactobacillus rhamnosus LRa05 leavening, and has the effects of remarkably correcting immune imbalance, improving the cellular immune function of a body and relieving the immune diseases such as eczema and the like; the invention has important application value in preparation of food or medicines for treating and / or preventing immune diseases. Particularly, the prepared food has remarkable clinical curative effects in the aspects of relieving eczema and reducing disease relapse, the physical state of a patient can be improved through daily diet, the microecosystem community structure and function in the intestinal tract can be adjusted, and troubles caused by immune diseases such as eczema and the like are reduced; patients get rid of fear and side effects caused by drug treatment, relapse is reduced, and the traditional Chinese medicine composition has important application value.

Description

technical field [0001] The invention belongs to the technical field of microbial fermentation, and relates to a direct-injection probiotic starter for alleviating immune diseases and an application thereof. Background technique [0002] According to the "Guidelines for the Diagnosis and Treatment of Eczema in China (2011)", eczema is a kind of disease that can make the skin itchy, inflamed or have rash-like appearance symptoms. It may exist in any age group, and even has a tendency to recur periodically. According to data analysis, about 7-10% of the population suffers from different degrees of eczema. Among them, eczema is a common allergic disease in infants and young children, with a common susceptibility and high recurrence rate, which seriously affects the quality of life of patients. The current treatment methods mostly use drug smearing or internal medicine to temporarily relieve itching, etc., but the effects of these treatments are not ideal, and even affect the gr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N1/20A61K35/747A61K9/19A61K47/26A61K47/22A61K47/36A61K47/44A61P37/02A61P37/08A61P17/00A23C9/13A23C9/133A23L33/135C12R1/46C12R1/225A61K35/744
CPCC12N1/20A61K35/744A61K35/747A61K9/19A61K47/26A61K47/22A61K47/36A61K47/44A61P37/02A61P37/08A61P17/00A23C9/1315A23C9/133A23L33/135A23V2002/00A61K2300/00A23V2200/3204A23V2200/324
Inventor 方曙光董瑶盖忠辉汪欣朱建国吴银琴
Owner JIANGSU WECARE BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products